| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2013 | CA2223608C Vaccine for porcine reproductive and respiratory syndrome virus |
| 01/03/2013 | WO2013003825A1 Alcaftadine for use in the treatment of urticaria |
| 01/03/2013 | WO2013003803A1 Topical formulations including lipid microcapsule delivery vehicles and their uses |
| 01/03/2013 | WO2013003689A2 Compositions containing nitro fatty acids |
| 01/03/2013 | WO2013003606A1 Predictive biomarker of survival in the treatment of renal cell carcinoma |
| 01/03/2013 | WO2013003601A1 Method for treating phytophotodermatitis |
| 01/03/2013 | WO2013003575A1 Method of administration and treatment |
| 01/03/2013 | WO2013003560A1 Method for treating eczema |
| 01/03/2013 | WO2013003505A1 Amido-pyridyl ether compounds and compositions and their use against parasites |
| 01/03/2013 | WO2013003475A1 Inhibition of innate immune response |
| 01/03/2013 | WO2013003467A2 Methods for treating ocular inflammatory disorders |
| 01/03/2013 | WO2013003445A1 Tetra-pyridine compounds and composition for protecting cells, tissues and organs against ischemia-reperfusion injury |
| 01/03/2013 | WO2013003386A1 3,5-diamino-6-chloro-n-(n-(4-(4-(2-(hexyl (2,3,4,5,6-pentahydroxyhexyl) amino) ethoxy) phenyl) butyl) carbamimidoyl) pyrazine-2-carboxamide |
| 01/03/2013 | WO2013003383A1 Bridged bicyclic compounds for the treatment of bacterial infections |
| 01/03/2013 | WO2013003360A1 Methods of treatment using allosteric processing inhibitors for matrix metalloproteinases |
| 01/03/2013 | WO2013003307A1 2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs |
| 01/03/2013 | WO2013003298A2 Inhibitors of pde10 |
| 01/03/2013 | WO2013003249A1 Novel crystalline forms of a dipeptidyl peptidase-iv inhibitor |
| 01/03/2013 | WO2013003236A1 Retinoid topical compositions and methods for treating skin conditions |
| 01/03/2013 | WO2013003114A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | WO2013003113A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | WO2013003112A1 Methods and compositions for treatment of cancer and autoimmune disease |
| 01/03/2013 | WO2013003001A1 Process for preparing heparinoids and intermediates useful in the synthesis thereof |
| 01/03/2013 | WO2013002969A1 Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents |
| 01/03/2013 | WO2013002749A1 Transepithelial methods of using gamma aminobutyric acid compositions for pain relief |
| 01/03/2013 | WO2013002733A1 Pharmaceutical compositions for treating cancer |
| 01/03/2013 | WO2013002485A2 Pharmaceutical composition for preventing and treating kidney disorders, containing inhibitor for phosphorylation of taz tyrosine as active ingredient for activation of nfat5/tonebp |
| 01/03/2013 | WO2013002484A1 Novel composition for preventing or treating hepatitis c virus, regulating phosphorylation of replicase |
| 01/03/2013 | WO2013002479A2 Nanoemulsion composition and method for preparing same |
| 01/03/2013 | WO2013002439A1 Antifungal composition comprising cis-cyclo(l-phe-l-pro) having genus ganoderma fungus-specific antifungal activity |
| 01/03/2013 | WO2013002428A1 Composition for improving and preventing snoring |
| 01/03/2013 | WO2013002421A1 Antimicrobial composition |
| 01/03/2013 | WO2013002420A1 Method for producing fine particles of aripiprazole anhydride crystals b |
| 01/03/2013 | WO2013002404A1 Method for alleviating fear memory |
| 01/03/2013 | WO2013002382A1 Nicorandil-containing pharmaceutical composition |
| 01/03/2013 | WO2013002365A1 Antipruritic agent |
| 01/03/2013 | WO2013002364A1 Crystals of glycine derivative and pharmaceutical use thereof |
| 01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
| 01/03/2013 | WO2013002331A1 Pharmaceutical preparation integrated with microneedles for skin treatment |
| 01/03/2013 | WO2013002313A1 Weight control drug |
| 01/03/2013 | WO2013002248A1 Phosphoric acid ester derivative |
| 01/03/2013 | WO2013002215A1 Cephem compound having pyridinium group |
| 01/03/2013 | WO2013002196A1 Novel pharmaceutical composition |
| 01/03/2013 | WO2013001890A1 Soyasapogenol composition |
| 01/03/2013 | WO2013001786A1 Eye fatigue suppression composition and food and drink containing same |
| 01/03/2013 | WO2013001544A1 Anti-thrombotic compounds |
| 01/03/2013 | WO2013001543A1 An optimized bilayered tablet dosage form with two active antibiotics: clavulanic acid and cefpodoxime |
| 01/03/2013 | WO2013001542A1 An optimized bilayered tablet with two active antibiotics: cefadroxil and clavulanic acid |
| 01/03/2013 | WO2013001541A1 An optimized bilayered tablet dosage form with high rate of bioavailability of two active antibiotics: cefuroxime and clavulanic acid |
| 01/03/2013 | WO2013001536A1 Stabilized topical formulations containing core-shell microcapsules |
| 01/03/2013 | WO2013001516A1 Multilayered dosage form |
| 01/03/2013 | WO2013001499A1 Indoleamine derivatives for the treatment of central nervous system diseases |
| 01/03/2013 | WO2013001498A1 Amidoalkylpiperazinyl derivatives for the treatment of central nervous system diseases |
| 01/03/2013 | WO2013001490A1 Novel anti-inflammatory dihydrochalcone derivatives and use thereof |
| 01/03/2013 | WO2013001457A1 Novel salts of sitagliptin |
| 01/03/2013 | WO2013001449A1 Pharmaceutical compositions containing hydroxypropyl methylcellulose and/or hyaluronic acid and their use |
| 01/03/2013 | WO2013001445A1 Solid forms and salts of tetrahydro-pyrido-pyrimidine derivatives |
| 01/03/2013 | WO2013001441A1 Dry formulations of febuxostat |
| 01/03/2013 | WO2013001412A1 Compositions for the treatment of fragile x syndrome |
| 01/03/2013 | WO2013001372A2 Methods and compositions for inhibition of activation of regulatory t cells |
| 01/03/2013 | WO2013001310A1 Macrocyclic compounds and their use as cdk8 inhibitors |
| 01/03/2013 | WO2013001294A1 Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
| 01/03/2013 | WO2013001192A1 Novel esters of n-acylated derivatives of amino acids and isosorbide, method for preparing same, and use thereof in cosmetics and as drug |
| 01/03/2013 | WO2013001167A1 Non-toxic compositions for decreasing the risk of cancer caused by oral microbes |
| 01/03/2013 | WO2013001126A1 Acylation method for producing food and/or pharmaceutical compounds using fungal sterol esterases |
| 01/03/2013 | WO2013001080A1 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | WO2013001073A1 A new stable anesthetic composition for reducing skin reactions |
| 01/03/2013 | WO2013001030A1 Oxazetidine derivatives, process for preparing them and use thereof in human medicine and in cosmetics |
| 01/03/2013 | WO2013000994A1 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | WO2013000974A1 Methods for treating immune-mediated diseases of the nervous system administering a compound comprising agents that inhibit prokineticin receptors activity |
| 01/03/2013 | WO2013000934A1 Milk drink based on oyster mushroom lovastatin |
| 01/03/2013 | WO2013000924A1 1-ARYL-4-METHYL-[1,2,4]TRIAZOLO[4,3-a]QUINOXALINE DERIVATIVES |
| 01/03/2013 | WO2013000917A1 Topical ophthalmological pharmaceutical composition containing regorafenib |
| 01/03/2013 | WO2013000909A1 Topical ophthalmological pharmaceutical composition containing sorafenib |
| 01/03/2013 | WO2013000895A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | WO2013000856A1 Hcv combination therapy |
| 01/03/2013 | WO2013000855A1 Hcv combination therapy |
| 01/03/2013 | WO2013000778A1 Applicator system for applying a viscous liquid to the human skin |
| 01/03/2013 | WO2013000651A1 Fluorinated arylalkylaminocarboxamide derivatives |
| 01/03/2013 | WO2013000578A1 Controlled release oral dosage form comprising oxycodone |
| 01/03/2013 | WO2013000543A1 Benzopyranobenzothiazinones and their use as fungicides, antibiotics and antitumor agents |
| 01/03/2013 | WO2013000406A1 Benzocycloheptanethiophene derivatives for anti-allergic reactions |
| 01/03/2013 | WO2013000399A1 Substituted cinnamamide derivative, preparation method and use thereof |
| 01/03/2013 | WO2013000395A1 Novel histone deacetylase inhibitor of benzamides and use thereof |
| 01/03/2013 | WO2013000392A1 Aripiprazole type i microcrystal, aripiprazole solid preparation, and preparation method |
| 01/03/2013 | WO2013000391A1 Aripiprazole medicament formulation and preparation method therefor |
| 01/03/2013 | WO2013000382A1 Fatty acid composition and plant extract and pharmaceutical preparation and application thereof |
| 01/03/2013 | WO2013000315A1 Guaiazulene derivative, preparation method and use thereof |
| 01/03/2013 | WO2013000286A1 Bufogenin derivatives, preparation methods, compositions containing such derivatives and uses thereof |
| 01/03/2013 | WO2013000280A1 9-sulfonyl-9h-purine derivative, preparation method and use thereof |
| 01/03/2013 | WO2013000275A1 C-glycoside derivatives |
| 01/03/2013 | WO2013000269A1 Camptothecin derivative, method for preparing same, pharmaceutical composition and use thereof |
| 01/03/2013 | WO2013000267A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use |
| 01/03/2013 | WO2013000209A1 Use of koumine in preparation of medicament for treatment of rheumatoid arthritis |
| 01/03/2013 | WO2013000108A1 Azole heterocylic compounds, preparation methods, pharmaceutical compositions and uses thereof |
| 01/03/2013 | WO2013000086A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | WO2013000085A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | WO2013000084A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | WO2013000064A1 Alternative splicing modulators and splice variants and their use in the control and detection of pluripotency and differentiation |
| 01/03/2013 | WO2013000054A1 Method for producing pterocarpans, cytomodulating composition containing pterocarpans, and use of pterocarpans |